期刊中文名:埃及制药杂志ISSN:1687-4315E-ISSN:2090-9853
该杂志国际简称:EGYPT PHARM J,是由出版商Wolters Kluwer Health出版的一本致力于发布--研究新成果的的专业学术期刊。主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载对学科发展起指导作用的综述与专论,促进学术发展,为广大读者服务。该刊是一本国际优秀杂志,在国际上有很高的学术影响力。
《Egyptian Pharmaceutical Journal》是一本以English为主的未开放获取国际优秀期刊,中文名称埃及制药杂志,本刊主要出版、报道领域的研究动态以及在该领域取得的各方面的经验和科研成果,介绍该领域有关本专业的最新进展,探讨行业发展的思路和方法,以促进学术信息交流,提高行业发展。该刊已被国际权威数据库SCIE收录,为该领域相关学科的发展起到了良好的推动作用,也得到了本专业人员的广泛认可。该刊最新影响因子为0.7,最新CiteScore 指数为1.1。
With the rapid development of the global pharmaceutical industry, especially the rise of emerging markets such as Egypt, there is increasing attention to pharmaceutical technology, drug research and development, production management, and market trends. The Egyptian Pharmaceutical Journal emerged with the aim of filling the information gap in this field and providing a platform for industry insiders and outsiders to exchange ideas, share experiences, and explore future trends. This magazine focuses on the latest developments in the pharmaceutical industry in Egypt, including but not limited to drug research and development, production processes, quality control, marketing, policies and regulations. Its purpose is to promote the healthy development of Egypt's pharmaceutical industry, drive technological innovation and industrial upgrading, while strengthening exchanges and cooperation with the international pharmaceutical industry.
The Egyptian Pharmaceutical Magazine enjoys high visibility and influence in the pharmaceutical industry in Egypt and even the entire Middle East region, thanks to its professional editorial team and extensive distribution network. It not only provides valuable information resources for people inside and outside the industry, but also promotes academic exchanges and cooperation, driving the continuous progress and development of the pharmaceutical industry.
按JIF指标学科分区 |
学科:PHARMACOLOGY & PHARMACY
收录子集:ESCI
分区:Q4
排名:317 / 354
百分位:
10.6% |
按JCI指标学科分区 |
学科:PHARMACOLOGY & PHARMACY
收录子集:ESCI
分区:Q4
排名:322 / 354
百分位:
9.18% |
JCR分区:JCR分区来自科睿唯安公司,JCR是一个独特的多学科期刊评价工具,为唯一提供基于引文数据的统计信息的期刊评价资源。每年发布的JCR分区,设置了254个具体学科。JCR分区根据每个学科分类按照期刊当年的影响因子高低将期刊平均分为4个区,分别为Q1、Q2、Q3和Q4,各占25%。JCR分区中期刊的数量是均匀分为四个部分的。
学科类别 | 分区 | 排名 | 百分位 |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | Q3 | 24 / 43 |
45% |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science | Q3 | 124 / 183 |
32% |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Biochemistry, Genetics and Molecular Biology (miscellaneous) | Q4 | 82 / 103 |
20% |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology | Q4 | 110 / 133 |
17% |
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Applied Microbiology and Biotechnology | Q4 | 109 / 127 |
14% |
该杂志是一本国际优秀杂志,在国际上有较高的学术影响力,行业关注度很高,已被国际权威数据库SCIE收录,该杂志在综合专业领域专业度认可很高,对稿件内容的创新性和学术性要求很高,作为一本国际优秀杂志,一般投稿过审时间都较长,投稿过审时间平均 ,如果想投稿该刊要做好时间安排。版面费不祥。该杂志近两年未被列入预警名单,建议您投稿。如您想了解更多投稿政策及投稿方案,请咨询客服。
若用户需要出版服务,请联系出版商。